GlassScriptPhysician profile
Cary Douglass
NPI 1477564342
$1,598.20
in general payments reported to CMS, 2019-2025
12 companies · $449 in 2025
The $449 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,149 · 2025: $449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $879 · Food and Beverage: $719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $879.46 |
| Food and Beverage | $718.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,199.20 | 2024-2025 | Airsupra, Farxiga |
| Exact Sciences Corporation | $92.86 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $47.77 | 2025 | Aptima |
| Abbott Laboratories | $46.81 | 2025 | Proclaim |
| Inspire Medical Systems, INC. | $42.47 | 2025 | Inspire |
| Glaxosmithkline, LLC. | $34.00 | 2025 | Arexvy, Shingrix |
| Pfizer INC. | $28.94 | 2025 | |
| Springworks Therapeutics, INC. | $27.73 | 2025 | Gomekli |
| Dexcom, INC. | $23.65 | 2025 | Dexcom G6 Transmitter |
| Tms Neurohealth Centers INC. | $23.37 | 2025 | Tms Neurohealth Centers INC. |
| Abbvie INC. | $16.61 | 2025 | |
| Lilly USA, LLC | $14.79 | 2025 | Kisunla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cary Douglass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.